![]() |
市場調查報告書
商品編碼
1847171
全球空心螺絲市場:市場規模、佔有率和趨勢分析(2025-2031 年)Cannulated Screw Market Size, Share, & Trends Analysis | Global | 2025-2031 | Includes: Stainless Steel Screws, and 1 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年全球空心螺絲市場規模為5.99億美元。預計到2031年,該市場規模將達到6.93億美元,年複合成長率為2.1%。
本報告涵蓋了所有帶孔螺絲產品,並按材質和尺寸等級進行了分類。報告涵蓋了不銹鋼和鈦合金螺絲,並對小型、中型和大型螺絲進行了單位分析。研究量化了銷售量、平均售價 (ASP)、市場規模、成長率和企業市場占有率。此外,報告還分析了市場促進因素和限制因素、手術趨勢、近期併購以及技術趨勢。報告提供截至 2021 年的歷史數據,並預測至 2031 年。
市場概覽
空心螺絲是整形外科創傷固定術的核心組成部分。其中空設計使其能夠沿著導管導引線插入,從而在多種適應症中提高操作性、對位性和精準度。外科醫生依靠空心螺絲來穩定骨折、進行截骨術以及輔助上下肢的固定手術。由於使用這些植入的手術通常至關重要且緊急,因此其需求在經濟週期中保持穩定。
創傷護理領域手術量的穩定性以及踝足手術、手腕手術和關節周圍融合術等廣泛領域的應用,持續推動市場的發展。然而,許多競標和聯合採購協議中也出現了價格壓力。這些因素導致學名藥的平均售價呈下降趨勢,而具有增值設計特性的產品,例如提高舒適度、減少軟組織刺激以及透過加壓促進癒合等,則可以維持價格。
材料的選擇會影響採購和臨床應用。鈦合金因其優異的生物相容性和輕質特性而不斷擴大市場佔有率。在許多地區,鈦合金和不銹鋼的價格差異正在縮小,這促使臨床醫生在處理小到中等骨折碎片時選擇鈦合金。不銹鋼在需要高剛度的領域中仍然發揮著重要作用,尤其是在大骨折碎片固定術和高負荷手術中。
產品研發主要集中在兩個方面。首先,在材料科學領域,正在研發新型鈦合金,以提高強度、耐久性和螺紋完整性,尤其是在髖關節和關節周圍區域。其次,在螺絲頭部設計方面,無頭空心螺絲的應用日益廣泛,這種螺絲能夠更好地黏附在骨表面,減少對軟組織的刺激。無頭設計的這種趨勢推高了該細分市場的平均售價(ASP),有助於緩解傳統帶頭螺絲產品的價格壓力。
各地區市場表現將有所不同。成熟市場由於採購集中化,傾向於大量採購標準尺寸產品,並優先考慮供應可靠性和服務響應速度。新興市場隨著創傷護理服務的改善,銷售量將有所成長,但公開競標定價可能面臨挑戰。總體而言,對必要手術的需求、鈦合金使用量的增加以及無頭設計產品的成長預計將共同推動整個預測期內保持個位數低成長。
市場促進因素
鈦的生長
鈦合金空心螺絲因其顯著的臨床優勢,且與不銹鋼螺絲相比價格差異相對較小,市場佔有率持續成長。鈦合金的生物相容性和輕質特性可提高患者舒適度並降低不良反應的風險。這些特性在用於手、腕、足部等部位的小直徑和中直徑螺釘中尤其重要,因為這些部位的軟組織相容性和長期相容性至關重要。
同時,供應商正投資研發新型鈦合金,旨在提升疲勞性能和螺紋耐久性。這些進步對於股骨頸固定和多碎片關節周圍骨折等複雜適應症尤其重要。隨著更多合金材料的上市,臨床醫師將能根據負荷、骨質和癒合目標等因素,更靈活地選擇合適的材料。對鈦合金的持續關注,有助於維持該品類平均售價的穩定,並推動其價值成長。
無頭螺絲的成長
無頭空心螺絲是成長迅速的細分市場。消除突出螺絲頭的設計降低了軟組織刺激和植入引起症狀的風險,從而減少了二次取出的需要。許多無頭系統採用雙螺紋或可調螺距結構,從兩端產生壓縮力。這項特性有助於在適當的早期活動和負重階段保持骨折碎片的對合和骨折碎片間的穩定性。
無頭螺釘的平均售價高於有頭螺釘,並且在包括舟骨、蹠骨和趾骨骨折以及某些踝關節和距下關節融合術在內的多個解剖部位均呈現較高的銷量成長率。隨著外科醫生致力於最大限度地減少患者的不適感和再次手術率,預計在整個預測期內,對無頭螺絲產品的需求將持續成長。
在急診手術中的作用
空心螺絲用於緊急手術,這些手術一旦進行就存在風險,必須立即進行。急診和創傷中心依靠它們快速固定髖關節、踝關節、腕關節和足部損傷。由於這些手術至關重要,其需求比擇期手術更為穩定。這種穩定性也意味著,與非緊急醫療器材市場相比,空心螺絲的價格往往更為堅挺,因為在非緊急醫療設備市場,競爭性競標會影響合約結果。
市場限制
平均售價(ASP)下降
儘管市場需求強勁,但空心螺絲的平均售價仍面臨來自集團採購組織、政府競標和基於價值的採購計劃的持續壓力。這些機制集中了採購力量,並加劇了價格競爭。在北美、西歐和中國等地區,價格持續受到壓縮,其中中國在2021年底實施政策調整後價格顯著下降。在預測期內,這些採購模式將繼續限制價格成長,並抑制傳統產品線的價值成長。
螺絲商品化
儘管無頭螺絲設計正逐漸獲得創新動力,但許多帶頭空心螺絲卻趨於同質化。產品差異化程度有限,標準帶頭螺絲產品線很少增加新功能。當產品被認為可以互換時,競標受單位成本和物流成本驅動。因此,帶頭螺絲的平均售價預計不會大幅上漲,該細分市場的成長將主要依賴銷量,而非價值。
足科醫生平均售價下降
踝關節手術領域的平均售價通常低於整形外科創傷領域。這反映了足病學領域中獨特的病例組合、採購模式和競爭環境。鑑於踝關節融合手術中空心螺絲的普遍使用,該管道較低的價格拉低了整體市場價值。雖然中空通常會提供捆綁銷售和標準套裝以提高效率,但平均售價的結構性差異預計仍將持續存在。
競爭分析
德普合成公司
2024年,DePuy Synthes繼續保持在空心螺絲市場的領先地位。該公司用途廣泛的空心螺絲產品線涵蓋小、中、大等多種尺寸。其主導地位得益於其全球規模、在創傷領域的深厚人脈以及為醫院和門診機構提供的可靠供應。憑藉其廣泛的分銷網路和與外科醫生偏好的契合度,預計DePuy Synthes將在整個預測期內保持其領先地位。
史賽克
史賽克在全球市佔率排名第二。該公司旗下的中空螺絲品牌包括Asnis III、AutoFix、Asnis Micro、TwinFix、Mini和Fixos。這些產品滿足不同的解剖結構需求,並具有簡化的器械操作和易於上手的特性。史賽克的策略是將螺絲產品線與更廣泛的創傷平台結合,以擴大基本客群。預計該公司將在保持市場佔有率的同時,充分利用相鄰且成長更快的創傷領域的成長潛力。
Zimmer Biomet
捷邁邦美憑藉其MAX VPC™螺絲系統和N-Force固定系統®保持了第三的位置。該公司在關鍵地區的市佔率保持穩定,並期望在競爭對手專注於其他高成長領域的市場擴大佔有率。均衡的定價和可靠的分銷網路為其在醫院競標和民營市場的持續參與提供了支持。
其他跨國公司和區域供應商則在特定地區或適應症領域競爭。這些公司通常專注於服務應對力、區域物流以及針對踝關節、足部或手部手術的特定產品線。雖然它們可能不會顯著改變全球市場佔有率,但它們加劇了區域競標中的價格競爭,並對同質化產品類別的平均售價(ASP)構成壓力。
市場和數據覆蓋範圍
單元分析按小型、中型和大型螺絲類別進行細分,並按地區對應到材料選擇。
科技與臨床趨勢
包括調查方法附錄和簡稱表。
圖表清單
圖表列表
調查方法
全球關稅的影響
空心螺絲市場
The global cannulated screw market was valued at $599 million in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching $693 million by 2031.
This report covers the full suite of cannulated screw products by material and size class. Scope includes stainless steel and titanium screws, with unit analysis across small, medium, and large screw categories. The study quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and examines market drivers and limiters, procedure dynamics, recent mergers and acquisitions, and technology trends. Historical data are provided to 2021, with forecasts through 2031.
Market Overview
Cannulated screws are a core element of orthopedic trauma fixation. Their hollow design allows placement over a guidewire, which improves control, alignment, and accuracy across a wide range of indications. Surgeons rely on cannulated screws to stabilize fractures, manage osteotomies, and support fusions in both upper and lower extremities. Because the procedures that use these implants are essential and often urgent, demand remains consistent across economic cycles.
The market continues to benefit from steady procedural volume in trauma care and from broader use in foot and ankle surgery, hand and wrist surgery, and periarticular fixation. At the same time, pricing pressure is present in many tenders and group purchasing agreements. These forces pull ASPs down for commoditized items, but value can be sustained where design features improve comfort, reduce soft tissue irritation, or enable compression that supports healing.
Material choice shapes purchasing and clinical use. Titanium has gained share due to favorable biocompatibility and lighter weight. The price gap between titanium and stainless steel is narrow in many regions, which encourages clinicians to select titanium for small and medium fragment cases. Stainless steel maintains a strong role where higher stiffness is desirable, especially in large fragment constructs and high-load indications.
Product development focuses on two areas. The first is material science, with suppliers exploring new titanium alloys that target strength, durability, and thread integrity, especially in hip and periarticular applications. The second is head design, where headless cannulated screws continue to gain use because they sit flush with bone and reduce soft tissue irritation. The trend toward headless designs supports higher ASPs within that subsegment and helps offset pricing pressure in traditional headed lines.
Regional performance varies. Mature markets with centralized procurement favor high-volume standard sizes and reward supply reliability and service response. Emerging markets expand units as access to trauma care improves, though pricing in public tenders may be tight. Overall, the balance of essential procedure demand, rising use of titanium, and growth in headless designs supports low single-digit value growth through the forecast period.
Market Drivers
Growth of Titanium
Titanium cannulated screws continue to expand share because the price difference versus stainless steel is often modest, while the clinical advantages are clear. Titanium's biocompatibility and lower weight can improve patient comfort and reduce the chance of adverse reactions. These characteristics are most valued in small and medium screws used in the hand, wrist, and foot, where soft tissue tolerance and long-term compatibility matter.
In parallel, suppliers are investing in new titanium alloys aimed at better fatigue performance and thread durability. These advances are particularly relevant for challenging indications such as femoral neck fixation or multi-fragment periarticular fractures. As more alloy options reach the market, clinicians will have greater ability to tailor material to load, bone quality, and healing goals. This sustained focus on titanium supports a stable ASP mix and incremental value growth in the category.
Growth of Headless Screws
Headless cannulated screws are a fast-growing subsegment. By eliminating a prominent screw head, these designs reduce soft tissue irritation and the risk of symptomatic hardware, which lowers the need for secondary removal. Many headless systems use dual-threaded or variable pitch constructs to generate compression from both ends. This feature helps draw fragments together and maintain interfragmentary stability during early motion and weight bearing where appropriate.
Headless screws carry higher ASPs than headed screws and demonstrate higher unit growth rates in several anatomical areas, including scaphoid, metatarsal, and phalangeal fractures, as well as selected ankle and subtalar fusions. As surgeons aim to minimize patient discomfort and reoperation rates, demand for headless options is expected to continue rising across the forecast period.
Role in Essential Surgery
Cannulated screws are used in non-elective procedures that cannot be deferred without risk. Emergency departments and trauma services rely on them for rapid fixation of hip, ankle, wrist, and foot injuries. Because these procedures are essential, unit demand is more stable than in categories tied to elective care. This stability also means pricing tends to be more resilient than in non-urgent device markets, although tender competition still influences contract outcomes.
Market Limiters
ASP Decreases
Despite healthy procedural demand, cannulated screw ASPs face steady pressure from group purchasing organizations, government tenders, and value-based procurement programs. These mechanisms concentrate purchasing power and focus competition on price. Regions such as North America, Western Europe, and China have seen persistent price compression, with China experiencing strong declines following policy changes introduced at the end of 2021. Over the forecast period, these procurement models will continue to limit pricing upside and hold back value growth in conventional lines.
Commoditization of Headed Screws
As headless designs capture the innovation spotlight, many headed cannulated screws have become commoditized. Product differentiation is limited, and few new features are expected for standard headed lines. When products are viewed as interchangeable, tenders emphasize unit price and logistics. As a result, headed screw ASPs are not expected to rise meaningfully, and market growth in that segment will be driven mainly by units rather than value.
Lower ASPs to Podiatrists
ASPs in foot and ankle surgery are generally lower than in trauma orthopedics. This reflects case mix, purchasing patterns, and competitive dynamics specific to podiatry. Because cannulated screws have significant use in foot and ankle fixation, the lower realized prices in that channel can weigh on overall market value. Vendors often respond through bundles and standard sets that increase efficiency, but the structural ASP gap is likely to persist.
Competitive Analysis
DePuy Synthes
DePuy Synthes held the leading share of the cannulated screw market in 2024. The company markets a broad portfolio under a generic Cannulated Screws line with multiple sizes across small, medium, and large classes. Leadership reflects global scale, deep relationships in trauma, and consistent supply across hospitals and ambulatory sites. Given its reach and alignment with surgeon preferences, DePuy Synthes is expected to maintain the top position through the forecast period.
Stryker
Stryker ranked second globally. Its cannulated screw brands include Asnis III, AutoFix, Asnis Micro, Twin Fix, MiNi, and Fixos. The range covers diverse anatomical needs and favors streamlined instrumentation and familiar handling. Stryker's strategy pairs screw portfolios with broader trauma platforms, which supports account penetration. The company is expected to hold share while leveraging growth from adjacent, faster-growing trauma segments.
Zimmer Biomet
Zimmer Biomet held the third position with the MAX VPC(TM) Screw System and N-Force Fixation System(R). The company's presence is steady in key regions, and share may expand in areas where competitors emphasize other higher-growth categories. Zimmer Biomet's balanced pricing and reliable distribution support ongoing participation in both hospital tenders and private markets.
Other multinational and regional suppliers compete in selected geographies and indications. These firms often focus on service responsiveness, regional logistics, and targeted product sets for foot and ankle or hand surgery. While they may not shift global shares dramatically, they contribute to price competition in local tenders and keep ASP pressure present in commoditized classes.
Market Coverage and Data Scope
Unit analysis is broken out by small, medium, and large screw classes and mapped to material choices by region.
Technology and Practice Trends
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within cannulated screws by material and size class through 2031.
How the shift to titanium and the rise of headless designs will influence ASPs, product mix, and purchasing decisions.
Which competitors are best positioned to defend or gain share in tenders and how portfolios compare on breadth, handling, and service.
How GPOs, government tendering, and value-based procurement programs affect pricing power across regions.
What design choices most reduce symptomatic hardware and reoperation risk in foot, ankle, hand, and wrist indications.
How vendors can use bundles, standardized sets, and service agreements to balance pricing pressure while sustaining value.
The Global Cannulated Screw Market Report from iData Research answers these questions with device-level sizing, company share analysis, and pricing detail.
Use it to quantify demand, prioritize product development, shape pricing strategy, and plan commercial execution across material and size segments.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Cannulated Screw Market